|
|
Volumn 6, Issue SUPPL. 6, 1995, Pages 7-13
|
|
Preclinical characteristics of gemcitabine
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CYTARABINE;
DEOXYCYTIDINE KINASE;
DEOXYCYTIDINE TRIPHOSPHATE;
DEOXYRIBONUCLEOTIDE;
DRUG METABOLITE;
GEMCITABINE;
GEMCITABINE DIPHOSPHATE;
GEMCITABINE TRIPHOSPHATE;
RIBONUCLEOTIDE REDUCTASE;
UNCLASSIFIED DRUG;
ANIMAL MODEL;
ANTINEOPLASTIC ACTIVITY;
CONFERENCE PAPER;
DNA DAMAGE;
DNA REPAIR;
DNA SYNTHESIS;
DNA SYNTHESIS INHIBITION;
DRUG ELIMINATION;
DRUG MECHANISM;
DRUG METABOLISM;
ENZYME INHIBITION;
HUMAN;
HUMAN CELL;
NONHUMAN;
PHOSPHORYLATION;
PRIORITY JOURNAL;
SOLID TUMOR;
|
|
EID: 0029584109
PISSN: 09594973
EISSN: None
Source Type: Journal
DOI: 10.1097/00001813-199512006-00002 Document Type: Conference Paper |
|
Times cited : (244)
|
|
References (0)
|
